Genpact Q2 revenue, adjusted profit beats estimates

Reuters
Aug 08
Genpact <a href="https://laohu8.com/S/QTWO">Q2</a> revenue, adjusted profit beats estimates

Overview

  • Genpact Q2 revenue grows 6.6% yr/yr, beating analyst expectations, per LSEG data

  • Adjusted EPS for Q2 rises 11.4%, beating consensus, per LSEG data

  • Co repurchased 700,000 shares for $30 mln

Outlook

  • Genpact expects Q3 revenue between $1.258 bln and $1.270 bln

  • Company forecasts full-year revenue of $4.958 bln to $5.053 bln

  • Genpact anticipates Q3 adjusted EPS of $0.89 to $0.90

  • Company sees full-year adjusted EPS of $3.51 to $3.58

Result Drivers

  • ADVANCED TECHNOLOGY SOLUTIONS - Revenue rose 17.3%, driven by demand for AI and digital technology services

  • DATA-TECH-AI GROWTH - Segment revenue increased 9.7%, contributing to nearly half of total net revenues

  • CORE BUSINESS SERVICES - Revenue increased 3.8%, reflecting steady demand for decision support and technology services

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$1.25 bln

$1.23 bln (8 Analysts)

Q2 Adjusted EPS

Beat

$0.88

$0.86 (9 Analysts)

Q2 EPS

$0.75

Q2 Net Income

$133 mln

Q2 Adjusted Income From Operations

Beat

$217 mln

$213 mln (7 Analysts)

Q2 Income From Operations

$179 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the business support services peer group is "buy"

  • Wall Street's median 12-month price target for Genpact Ltd is $50.00, about 15.6% above its August 6 closing price of $42.20

  • The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release: ID:nPn6Ns4f9a

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10